Ocular Therapeutix (OCUL) PT Raised to $11 at Raymond James
Raymond James analyst Dane Leone raised the price target on Ocular Therapeutix (NASDAQ: OCUL) to $11.00 (from $10.00) while maintaining a Strong Buy rating following FDA approval.
Raymond James analyst Dane Leone raised the price target on Ocular Therapeutix (NASDAQ: OCUL) to $11.00 (from $10.00) while maintaining a Strong Buy rating following FDA approval.